| Prev Close | 2.40 |
| Open | 2.39 |
| Day Low/High | 2.39 / 2.40 |
| 52 Wk Low/High | 0.82 / 2.53 |
| Volume | 2.05M |
| Avg Volume | 2.19M |
| Exchange | NASDAQ |
| Shares Outstanding | 119.24M |
| Market Cap | 284.99M |
| EPS | -0.10 |
| P/E Ratio | N/A |
| Div & Yield | N.A. (N.A) |
Latest News
LabCorp Commences Cash Tender Offer For All Outstanding Shares Of Sequenom, Inc.
Laboratory Corporation of America® Holdings (NYSE: LH) today announced the commencement of its cash tender offer for all outstanding shares of the common stock of Sequenom, Inc.
SHAREHOLDER ALERT: Brower Piven Commences An Investigation Into The Proposed Sale Of Sequenom, Inc. And Encourages Investors To Contact The Firm For Additional Information
The securities litigation law firm of Brower Piven, A Professional Corporation, has commenced an investigation into possible breaches of fiduciary duty and other violations of state law by the Board of Directors of...
These 5 Stocks Under $10 Are Set to Soar Higher
Here's a technical look at how to trade five stocks trading for less than $10 a share.
Sequenom Reaches Analyst Target Price
In recent trading, shares of Sequenom Inc have crossed above the average analyst 12-month target price of $1.18, changing hands for $2.35/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on valuation, or, re-adjust their target price to a higher level.
SEQUENOM, INC. SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation Of Buyout
Rigrodsky & Long, P.A.
LabCorp Announces Agreement To Acquire Sequenom
Acquisition Creates Market Leader in NIPT, Women's Health and Reproductive Genetics
LabCorp Announces Agreement To Acquire Sequenom
Laboratory Corporation of America®  Holdings (LabCorp®) (NYSE:LH), the world's leading healthcare diagnostics company, and Sequenom, Inc.
Sequenom Laboratories™ Announces Significant Enhancement To MaterniT® GENOME And Will Present New Data At The 20th International Conference On Prenatal Diagnosis And Therapy
30% of MaterniT® GENOME positive findings could be detected only with genome-wide testing
Insider Trading Alert - KSU, TLMR And SQNM Traded By Insiders
Stocks with insider trader activity include KSU, TLMR and SQNM
Sophiris Bio Tops Dollar-Stock Gainers on Trial Success of Cancer Treatment
Shares of the urology company surge in postmarket trading Thursday.
Insider Trading Alert - SQNM, OFIX And CIEN Traded By Insiders
Stocks with insider trader activity include SQNM, OFIX and CIEN
Sequenom Strengthens Executive Team With New Vice President Of Sales
Medical Diagnostics Industry Veteran Will Help Drive Growth of Sequenom Laboratories Tests in New and Existing Channels
Sequenom Announces Contract With Anthem BlueCross
Agreement covers Noninvasive Prenatal Tests in California
Sequenom Laboratories Announces Positive Results From Clinical Validation Study On The MaterniT® GENOME Test
Test can detect up to 25% more chromosomal information genome-wide than other leading NIPTs
